Momentus, X4 Pharmaceuticals, and ReShape Lifesciences are the 3 Penny Stocks to watch on August 14, 2025, based on TipRanks’ Penny Stock Screener tool. Penny stocks are defined as stocks that trade at or below $5 per share and have a market capitalization below $300 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The Penny Stock Screener helps investors scan stocks based on numerous parameters, including Sector, Price Target Upside, Smart Score, Analyst Consensus, Dollar Volume, and Price Change.
We leveraged the tool to pick the top three penny stocks with the highest Dollar Volume as of the close on August 13, 2025. Simply put, Dollar Volume is the number of shares traded on a particular day multiplied by the day’s share price.
Momentus (MNTS) – Momentus is an American spaceflight company that focuses on providing space infrastructure services, particularly on-orbit transportation services using spacecraft electric propulsion. On August 13, MNTS had a Dollar Volume of $617.87 million, while its stock price skyrocketed by more than 72%.
Yesterday, Momentus announced a contract with NASA (National Aeronautics and Space Administration), under which it will conduct a study on flying critical foundational robotics technologies into space. Additionally, Momentus noted that NASA intends to award a contract for a follow-up study in September.
X4 Pharmaceuticals (XFOR) – X4 Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare immune system diseases and chronic neutropenic disorders. Yesterday, XFOR had a Dollar Volume of $226.69 million, accompanied by a stock price surge of 13.6%.
On August 13, XFOR announced the closing of an upsized $85 million private placement, increased from the originally planned $60 million to include an investor with pre-existing rights. The proceeds will be used to support the development of mavorixafor for chronic neutropenia and the commercialization of WHIM syndrome.
ReShape Lifesciences (RSLS) – ReShape Lifesciences is a MedTech company focused on the development of minimally-invasive medical devices and offering integrated solutions to treat obesity and metabolic diseases. On Wednesday, RSLS had a Dollar Volume of $140.03 million, while its stock price surged by 57.6%.
RSLS shares jumped after Vyome Therapeutics, a clinical-stage healthcare company announced that the Nasdaq Stock Market had approved its listing upon completion of the company’s previously announced merger with ReShape Lifesciences. The combined company will begin trading on August 15, under the new name Vyome Holdings and ticker “HIND.”
To find more penny stocks like these, you can take a look at TipRanks’ Penny Stock Screener tool. It shows a list of all penny stocks, their price movement, and other vital data.